|Home||» Products||» Pharmaceutical Formulations||» Aprepitant 125 mg Capsules|
Aprepit contains aprepitant, which lies in the class of medicines known as antiemetics. Aprepitant, in accumulation with some other antiemetic agents, is recommended for the prevention of chronic and delayed nausea and vomiting related with initial and repeated courses of extremely emetogenic cancer chemotherapy, including high-dose cisplatin. It is used for the therapy in adult patients with chemotherapy induced vomiting and nausea. Aprepitant is taken for 3 days as the part of the regimens, which includes a corticosteroid and a 5-HT3 antagonist. The suggested dose of this medicine is 125 mg by mouth 1 hour prior to chemotherapy management (Day 1) and 80 mg one time daily in the morning on Days 2 and 3.
Aprepitant 125 mg Capsules is also recommended for the prevention of acute and prolonged nausea and vomiting, which are associated with initial and recurrent orbits of extremely emetogenic cancer chemotherapy including high-dose . Aprepit in accumulation with some other antiemetic agents is pointed to cure nausea and vomiting grounded by cancer chemotherapy treatment. This prescription drug should be taken under comely medical counseling and advice. Do not share the medicament with some others, since they may be troubled with a problem, which is not efficaciously medicated by this drug.
VEA IMPEX All Rights Reserved.